166 related articles for article (PubMed ID: 3891875)
61. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
62. [Monoclonal antibodies in pigmented lesions].
Puig L; Moreno A; Moragas JM
Med Cutan Ibero Lat Am; 1987; 15(6):481-8. PubMed ID: 3323707
[TBL] [Abstract][Full Text] [Related]
63. Immunohistologic evidence for the malignant potential of congenital melanocytic nevi.
Steijlen PM; Hamm H; van Erp EJ; Johnson JP; Ruiter DJ; Bröcker EB
J Invest Dermatol; 1989 Mar; 92(3):366-70. PubMed ID: 2645372
[TBL] [Abstract][Full Text] [Related]
64. Superficial congenital compound melanocytic nevus. Another pitfall in the diagnosis of malignant melanoma.
Hurwitz RM; Buckel LJ
Dermatol Surg; 1997 Oct; 23(10):897-900. PubMed ID: 9357498
[TBL] [Abstract][Full Text] [Related]
65. On the histological diagnosis and prognosis of malignant melanoma.
Levene A
J Clin Pathol; 1980 Feb; 33(2):101-24. PubMed ID: 6988460
[TBL] [Abstract][Full Text] [Related]
66. Nevus cell aggregates massively occupying parenchyma of an external iliac lymph node: A case report and review of the literature.
Hu J; Ren M; Cai X; Zhang Y; Lv JJ; Kong YY
J Cutan Pathol; 2020 Dec; 47(12):1175-1180. PubMed ID: 32644206
[TBL] [Abstract][Full Text] [Related]
67. [In vivo differentiation of pigmented skin tumors with laser Doppler perfusion imaging].
Stücker M; Hoffmann M; Memmel U; von Bormann C; Hoffmann K; Altmeyer P
Hautarzt; 2002 Apr; 53(4):244-9. PubMed ID: 12053691
[TBL] [Abstract][Full Text] [Related]
68. [Dysplastic melanocytic nevus].
Salava A; Ranki A; Saksela O
Duodecim; 2010; 126(21):2492-501. PubMed ID: 21171474
[TBL] [Abstract][Full Text] [Related]
69. Dysplasia, dysplastic melanocytes, dysplastic nevi, the dysplastic nevus syndrome, and the relation between dysplastic nevi and malignant melanomas.
Ackerman AB; Mihara I
Hum Pathol; 1985 Jan; 16(1):87-91. PubMed ID: 3972389
[No Abstract] [Full Text] [Related]
70. [Proliferative nodule in a congenital melanocytic nevus].
López V; Martín JM; Jordá E
Actas Dermosifiliogr; 2010; 101(1):102-3. PubMed ID: 20109406
[No Abstract] [Full Text] [Related]
71. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
[TBL] [Abstract][Full Text] [Related]
72. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
Boyd AS; Shakhtour B; Shyr Y
J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
[TBL] [Abstract][Full Text] [Related]
73. Specification and use of a mouse monoclonal antibody raised against melanosomes for the histopathologic diagnosis of amelanotic malignant melanoma.
Maeda K; Maeda K; Jimbow K
Cancer; 1988 Sep; 62(5):926-34. PubMed ID: 3044572
[TBL] [Abstract][Full Text] [Related]
74. Increased epidermal growth factor receptors in melanocytic lesions.
Ellis DL; King LE; Nanney LB
J Am Acad Dermatol; 1992 Oct; 27(4):539-46. PubMed ID: 1383295
[TBL] [Abstract][Full Text] [Related]
75. Melanocytic nevi, dysplastic nevi, and malignant melanoma in children from melanoma-prone families.
Novakovic B; Clark WH; Fears TR; Fraser MC; Tucker MA
J Am Acad Dermatol; 1995 Oct; 33(4):631-6. PubMed ID: 7673498
[TBL] [Abstract][Full Text] [Related]
76. Development of a novel noninvasive adhesive patch test for the evaluation of pigmented lesions of the skin.
Gerami P; Alsobrook JP; Palmer TJ; Robin HS
J Am Acad Dermatol; 2014 Aug; 71(2):237-44. PubMed ID: 24906614
[TBL] [Abstract][Full Text] [Related]
77. Determination of proliferating fractions in malignant melanomas by anti-PCNA/cyclin monoclonal antibody.
Takahashi H; Strutton GM; Parsons PG
Histopathology; 1991 Mar; 18(3):221-7. PubMed ID: 1675189
[TBL] [Abstract][Full Text] [Related]
78. The utility of PRAME staining in identifying malignant transformation of melanocytic nevi.
Lohman ME; Steen AJ; Grekin RC; North JP
J Cutan Pathol; 2021 Jul; 48(7):856-862. PubMed ID: 33433032
[TBL] [Abstract][Full Text] [Related]
79. Significant melanocytic lesions in infancy, childhood, and adolescence.
Hoss DM; Grant-Kels JM
Dermatol Clin; 1986 Jan; 4(1):29-44. PubMed ID: 3521978
[TBL] [Abstract][Full Text] [Related]
80. [Morphological changes in melanocytic nevi induced by exogenous factors].
Tronnier M; Alexander M; Neitmann M; Brinckmann J; Wolff HH
Hautarzt; 2000 Aug; 51(8):561-6. PubMed ID: 10997310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
